Strategies & Technologies Driving Drug Discovery to Market
Subscribe to Drug Discovery & Development All

The Lead

Meet the Head of Bayer's U.S. Science Hub: Chris Haskell

March 27, 2015 | by Ryan Bushey, Associate Editor | Articles | Comments

Haskell's role is to establish partnerships with life science startups working on intriguing projects. Read more...

View Sample

FREE Email Newsletter

DDD Update

Daily news and top headlines for drug research professionals

BioDelivery Sciences’ Pain Treatment Fails Study

March 30, 2015 3:46 pm | by Stephanie Guzowski, Editor | News | Comments

BioDelivery Sciences International Inc. said on Monday its pain drug for diabetic neuropathy failed to meet the primary goal in a Phase 3 clinical trial. Shares fell nearly 30 percent. Read more...


Novo to Launch Novoeight in the U.S. for People With Hemophilia A

March 29, 2015 3:38 pm | News | Comments

The US Food and Drug Administration (FDA) approved Novoeight for use in adults and children with hemophilia A for the control and prevention of bleeding, perioperative management, and routine prophylaxis. Read more...


Integrative Approaches Key to Understanding Cancer and Developing Therapies

March 29, 2015 3:16 pm | by Moffitt Cancer Center | News | Comments

Researchers are using integrative approaches to study cancer by combining mathematical and computational modeling with experimental and clinical data. Read more...


Cells Rebound after Treatment for Most Children with HIV, Low Immune Cell Count

March 27, 2015 2:13 pm | by Enrique Rivero, UCLA | News | Comments

Most children with HIV who have low levels of a key immune cell eventually recover levels of this cell after they begin treatment. Read more...

MRI based on Sugar Molecule Can Tell Cancerous from Noncancerous Cells

March 27, 2015 2:06 pm | by Johns Hopkins University | News | Comments

Preliminary study in lab-grown cells raises possibility of cancer diagnosis without biopsies. Read more...


Nanoparticle Therapy Promotes Wound Healing

March 27, 2015 2:00 pm | by Yeshiva University | News | Comments

An experimental therapy can cut in half the time it takes to heal wounds compared to no treatment at all. Read more...


Answers to Common Questions about HIV, Needles, and Drug Use

March 27, 2015 1:47 pm | by Carla K. Johnson, AP Medical Writer | News | Comments

Indiana Gov. Mike Pence has authorized a short-term needle-exchange program and other steps to help contain the spread of HIV among intravenous drug users in one county. Read more...


Eisai Receives Japanese Approval for Anticancer Agent

March 27, 2015 1:40 pm | News | Comments

Eisai announced that it has received manufacturing and marketing authorization in Japan for its in-house developed novel anticancer agent. Read more...


White House Releases Plan to Fight Antibiotic Resistance

March 27, 2015 12:58 pm | by Stephanie Guzowski, Editor | News | Comments

The White House has revealed today its comprehensive plan to tackle antibiotic resistance within the next five years, according to a copy of the 60-page report, which was reviewed by Reuters. Read more...


Researchers Create Method for Measuring Early Sign of Alzheimer's

March 27, 2015 10:36 am | by UCLA | News | Comments

After six years of painstaking research, a UCLA-led team has validated the first standardized protocol for measuring one of the earliest signs of Alzheimer’s disease — the atrophy of the part of the brain known as the hippocampus. Read more...


Indiana Governor Overrides Law to Authorize Needle Exchange

March 27, 2015 10:32 am | by Rick Callahan, AP | News | Comments

Indiana Gov. Mike Pence overrode state law and his own anti-drug policies Thursday to authorize a short-term needle-exchange program designed to help contain HIV infections in a rural county where more than six dozen cases have been reported, all of them tied to intravenous drug use. Read more...


Roseroot Shows Promise as Potential Depression Treatment Option

March 27, 2015 10:27 am | by Penn University | News | Comments

Rhodiola rosea (R. rosea), or roseroot, may be a beneficial treatment option for major depressive disorder (MDD), according to results of a study in the journal Phytomedicine. Read more...


Gelesis Closes $22M Equity Financing

March 27, 2015 10:21 am | News | Comments

Gelesis, a clinical stage biotechnology company focused on the development of first-in-class products to induce weight loss and improve glycemic control, announced today that it closed an equity financing of shares of convertible preferred stock for gross proceeds of approximately $22 million. Read more...


Precision Medicine Shaping the Future of Cancer Research

March 27, 2015 8:41 am | by Columbia University | News | Comments

Nearly 50 years after the “war on cancer” was declared in the United States, precision medicine presages an era of increased understanding of the molecular basis of cancer and of the ability to design treatments. Read more...

Sierra Leoneans to Stay Home in Final Push to Stop Ebola

March 27, 2015 8:32 am | by Clarence Roy-Macaulay, Associated Press | News | Comments

Sierra Leone's 6 million people were told to stay home for three days, except for religious services, beginning Friday as the West African nation attempted a final push to rid itself of Ebola. Read more...



You may login with either your assigned username or your e-mail address.
The password field is case sensitive.